| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +7.13% | +9.62% | +51.94% | +166.83% | 1,006B | |
| +3.99% | +10.10% | +67.53% | +55.63% | 589B | |
| +4.20% | +10.15% | +35.63% | +87.74% | 430B | |
| -0.66% | +5.11% | +29.26% | +21.27% | 331B | |
| +1.82% | +8.85% | +39.72% | +25.35% | 288B | |
| +0.22% | +6.98% | +32.93% | +39.24% | 285B | |
| +0.73% | +13.51% | -26.95% | -41.57% | 213B | |
| +1.56% | +3.95% | +28.38% | +59.45% | 190B | |
| +3.26% | +2.41% | +18.83% | +67.03% | 154B | |
| Average | +2.10% | +5.96% | +30.81% | +53.44% | 387.31B | |
| Weighted average by Cap. | +3.56% | +5.38% | +40.28% | +79.34% |
Employees
4
Sector
Pharmaceuticals
